{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:17:50Z","timestamp":1790306270877,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["12825"],"award-info":[{"award-number":["12825"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["16523"],"award-info":[{"award-number":["16523"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.it.2025.10.007","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T02:52:33Z","timestamp":1762570353000},"page":"160-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epigenetically programmed identity crisis to combat diffuse large B cell lymphoma"],"prefix":"10.1016","volume":"47","author":[{"given":"Rachele","family":"Niccolai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camiel","family":"G\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6227-9850","authenticated-orcid":false,"given":"Heinz","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2025.10.007_bb0005","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.immuni.2021.07.015","article-title":"The unique biology of germinal center B cells","volume":"54","author":"Young","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.it.2025.10.007_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.coi.2016.12.004","article-title":"Germinal centers: programmed for affinity maturation and antibody diversification","volume":"45","author":"Bannard","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0015","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","article-title":"Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study","volume":"130","author":"Crump","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.it.2025.10.007_bb0020","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2025.10.007_bb0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tips.2014.01.001","article-title":"Exploiting epigenetic vulnerabilities for cancer therapeutics","volume":"35","author":"Mair","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.it.2025.10.007_bb0030","doi-asserted-by":"crossref","unstructured":"G\u00f6bel, C. et al. Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of diffuse large B cell lymphoma. Blood 145, 1802\u20131813","DOI":"10.1182\/blood.2024025500"},{"key":"10.1016\/j.it.2025.10.007_bb0035","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1182\/blood.2024026534","article-title":"Synergistic antitumor effect of combined EZH2 and DOT1L inhibition in B-cell lymphoma","volume":"145","author":"Thuy","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.it.2025.10.007_bb0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri2217","article-title":"Germinal centres: role in B-cell physiology and malignancy","volume":"8","author":"Klein","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0045","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.immuni.2016.09.001","article-title":"Germinal center B cell dynamics","volume":"45","author":"Mesin","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.it.2025.10.007_bb0050","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/cmi.2017.133","article-title":"Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity","volume":"15","author":"Wu","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0055","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.immuni.2009.01.011","article-title":"Initial clonal expansion of germinal center B cells takes place at the perimeter of follicles","volume":"30","author":"Coffey","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.it.2025.10.007_bb0060","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ni1454","article-title":"Pax5: the guardian of B cell identity and function","volume":"8","author":"Cobaleda","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.immuni.2019.07.001","article-title":"Class-switch recombination occurs infrequently in germinal centers","volume":"51","author":"Roco","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.it.2025.10.007_bb0070","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1073\/pnas.0437996100","article-title":"Transcriptional analysis of the B cell germinal center reaction","volume":"100","author":"Klein","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.10.007_bb0075","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.immuni.2016.01.011","article-title":"Independent roles of switching and hypermutation in the development and persistence of B lymphocyte memory","volume":"44","author":"Gitlin","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.it.2025.10.007_bb0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.immuni.2015.12.004","article-title":"A temporal switch in the germinal center determines differential output of memory B and plasma cells","volume":"44","author":"Weisel","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.it.2025.10.007_bb0085","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0167-5699(00)01687-X","article-title":"Dissecting affinity maturation: a model explaining selection of antibody-forming cells and memory B cells in the germinal centre","volume":"21","author":"Tarlinton","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1016\/j.it.2025.10.007_bb0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/imr.13016","article-title":"Memory B cells and plasma cells: the differentiative continuum of humoral immunity","volume":"303","author":"Cancro","year":"2021","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.it.2025.10.007_bb0095","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/ni.2428","article-title":"The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry","volume":"13","author":"Dominguez-Sola","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0100","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/ni.2418","article-title":"The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers","volume":"13","author":"Calado","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0105","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nature03147","article-title":"The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells","volume":"432","author":"Phan","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.10.007_bb0110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","article-title":"Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme","volume":"102","author":"Muramatsu","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.it.2025.10.007_bb0115","doi-asserted-by":"crossref","first-page":"E3649","DOI":"10.1073\/pnas.1602025113","article-title":"Defining chromosomal translocation risks in cancer","volume":"113","author":"Hogenbirk","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.10.007_bb0120","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fimmu.2019.00438","article-title":"Mutating for good: DNA damage responses during somatic hypermutation","volume":"10","author":"Pilzecker","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0125","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","article-title":"Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue","volume":"123","author":"Scott","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.it.2025.10.007_bb0130","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051184","article-title":"Histone methyltransferase DOT1L controls state-specific identity during B cell differentiation","volume":"22","author":"Aslam","year":"2021","journal-title":"EMBO Rep."},{"key":"10.1016\/j.it.2025.10.007_bb0135","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","article-title":"EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation","volume":"23","author":"B\u00e9guelin","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2025.10.007_bb0140","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ni1245","article-title":"BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells","volume":"6","author":"Phan","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0145","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nri953","article-title":"Lymphoid malignancies: the dark side of B-cell differentiation","volume":"2","author":"Shaffer","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.1062589","article-title":"Arrested differentiation, the self-renewing memory lymphocyte, and vaccination","volume":"293","author":"Fearon","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.it.2025.10.007_bb0155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/j.seminhematol.2023.11.004","article-title":"Epidemiology and etiology of diffuse large B-cell lymphoma","volume":"60","author":"Wang","year":"2023","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.it.2025.10.007_bb0160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.clim.2014.10.002","article-title":"Effective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells","volume":"155","author":"Wang","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0165","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric antigen receptor T cells in refractory B-cell lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2025.10.007_bb0170","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2025.10.007_bb0175","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood-2012-03-415380","article-title":"Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas","volume":"120","author":"Victora","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.it.2025.10.007_bb0180","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.10.007_bb0185","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.10.007_bb0190","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.it.2025.10.007_bb0195","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev-immunol-020711-075027","article-title":"Pathogenesis of human B cell lymphomas","volume":"30","author":"Shaffer","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0200","doi-asserted-by":"crossref","unstructured":"Ku\u00e8, R. and Dalla-Favera, R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20, 5580\u20135594","DOI":"10.1038\/sj.onc.1204640"},{"key":"10.1016\/j.it.2025.10.007_bb0205","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2025.10.007_bb0210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.seminhematol.2015.01.005","article-title":"The genetic landscape of diffuse large B-cell lymphoma","volume":"52","author":"Pasqualucci","year":"2015","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.it.2025.10.007_bb0215","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/imr.12755","article-title":"Germinal center-derived lymphomas: the darkest side of humoral immunity","volume":"288","author":"Mlynarczyk","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.it.2025.10.007_bb0220","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1182\/blood-2010-04-280149","article-title":"EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis","volume":"116","author":"Velichutina","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.it.2025.10.007_bb0225","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/s41375-019-0392-1","article-title":"EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation","volume":"33","author":"Herviou","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2025.10.007_bb0230","doi-asserted-by":"crossref","unstructured":"Grossmann, V. et al. EZH2 mutations are frequent and represent an early event in follicular lymphoma. Blood 122, 3165\u20133168","DOI":"10.1182\/blood-2013-04-496893"},{"key":"10.1016\/j.it.2025.10.007_bb0235","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.it.2025.10.007_bb0240","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ccell.2020.04.004","article-title":"Mutant EZH2 Induces a pre-malignant lymphoma niche by reprogramming the immune response","volume":"37","author":"B\u00e9guelin","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2025.10.007_bb0245","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1172\/JCI70626","article-title":"Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis","volume":"123","author":"Caganova","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2025.10.007_bb0250","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4049\/jimmunol.1701470","article-title":"EZH2 represses the B cell transcriptional program and regulates antibody-secreting cell metabolism and antibody production","volume":"200","author":"Guo","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0255","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0092-8674(02)00759-6","article-title":"Dot1p modulates silencing in yeast by methylation of the nucleosome core proteins and with the nucleosomes","volume":"109","author":"Van Leeuwen","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.it.2025.10.007_bb0260","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.15252\/embr.201438793","article-title":"Flexibility in crosstalk between H2B ubiquitination and H3 methylation in vivo","volume":"15","author":"Vlaming","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.it.2025.10.007_bb0265","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00412-015-0570-5","article-title":"The upstreams and downstreams of H3K79 methylation by DOT1L","volume":"125","author":"Vlaming","year":"2016","journal-title":"Chromosoma"},{"key":"10.1016\/j.it.2025.10.007_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108504","article-title":"The histone methyltransferase DOT1L is essential for humoral immune responses","volume":"33","author":"Kealy","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.it.2025.10.007_bb0275","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2104013118","article-title":"Role of Dot1L and H3K79 methylation in regulating somatic hypermutation of immunoglobulin genes","volume":"118","author":"Duan","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.10.007_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1385319","article-title":"An emerging maestro of immune regulation: how DOT1L orchestrates the harmonies of the immune system","volume":"15","author":"Kealy","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0285","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41590-018-0273-1","article-title":"Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis","volume":"20","author":"Hatzi","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0290","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.4049\/jimmunol.1800952","article-title":"The histone demethylase LSD1 regulates B cell proliferation and plasmablast differentiation","volume":"201","author":"Haines","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0295","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12032-021-01572-0","article-title":"The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy","volume":"38","author":"Liu","year":"2021","journal-title":"Med. Oncol."},{"key":"10.1016\/j.it.2025.10.007_bb0300","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/ni.2524","article-title":"Plasma cells require autophagy for sustainable immunoglobulin production","volume":"14","author":"Pengo","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0305","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fimmu.2014.00103","article-title":"Autophagy in plasma cell pathophysiology","volume":"5","author":"Oliva","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0310","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-biochem-051710-134100","article-title":"The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis","volume":"81","author":"Shilatifard","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.it.2025.10.007_bb0315","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2025.10.007_bb0320","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/nm.3943","article-title":"The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development","volume":"21","author":"Ortega-Molina","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2025.10.007_bb0325","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.10.007_bb0330","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1182\/blood.2019000962","article-title":"KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas","volume":"136","author":"Ferrari","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.it.2025.10.007_bb0335","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1038\/ncomms5273","article-title":"Shp1 signalling is required to establish the long-lived bone marrow plasma cell pool","volume":"5","author":"Li","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2025.10.007_bb0340","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1158\/2159-8290.CD-16-0975","article-title":"CREBBP inactivation promotes the development of HDAC3-dependent lymphomas","volume":"7","author":"Jiang","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.it.2025.10.007_bb0345","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1158\/2159-8290.CD-16-1417","article-title":"The CREBBP acetyltransferase is a haploinsufficient tumor suppressor in B-cell lymphoma","volume":"7","author":"Zhang","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.it.2025.10.007_bb0350","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.immuni.2019.08.006","article-title":"Unique and shared epigenetic programs of the CREBBP and EP300 acetyltransferases in germinal center B cells reveal targetable dependencies in lymphoma","volume":"51","author":"Meyer","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.it.2025.10.007_bb0355","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.10.007_bb0360","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/2159-8290.CD-19-0116","article-title":"Selective inhibition of HDAC3 targets synthetic vulnerabilities and activates immune surveillance in lymphoma","volume":"10","author":"Mondello","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.it.2025.10.007_bb0365","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500447","article-title":"Mammalian SWI\/SNF chromatin remodeling complexes and cancer: mechanistic insights gained from human genomics","volume":"1","author":"Kadoch","year":"2015","journal-title":"Sci. Adv."},{"key":"10.1016\/j.it.2025.10.007_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.705848","article-title":"Brg1 supports B cell proliferation and germinal center formation through enhancer activation","volume":"12","author":"Schmiedel","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.10.007_bb0375","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccell.2024.02.011","article-title":"SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions","volume":"42","author":"Deng","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2025.10.007_bb0380","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3324\/haematol.2020.274258","article-title":"Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma","volume":"107","author":"Ma","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.it.2025.10.007_bb0385","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ccell.2024.02.010","article-title":"ARID1A orchestrates SWI\/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis","volume":"42","author":"Barisic","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2025.10.007_bb0390","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nm.3799","article-title":"Targeting EZH2 methyltransferase activity in ARID1A mutated cancer cells is synthetic lethal","volume":"21","author":"Bitler","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2025.10.007_bb0395","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ccr.2010.09.006","article-title":"Epigenetic antagonism between polycomb and SWI\/SNF complexes during oncogenic transformation","volume":"18","author":"Wilson","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2025.10.007_bb0400","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2017-11-764332","article-title":"Genetics of diffuse large B-cell lymphoma","volume":"131","author":"Pasqualucci","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.it.2025.10.007_bb0405","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.805195","article-title":"Epigenetic, metabolic, and immune crosstalk in germinal-center-derived B-cell lymphomas: unveiling new vulnerabilities for rational combination therapies","volume":"9","author":"Serganova","year":"2022","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.it.2025.10.007_bb0410","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.it.2025.10.007_bb0415","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era","volume":"117","author":"P\u00e9 Rez-Gal\u00e1n","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2025.10.007_bb0420","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrd.2017.111","article-title":"Opportunities and challenges in phenotypic drug discovery: an industry perspective","volume":"16","author":"Moffat","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.it.2025.10.007_bb0425","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41467-018-07905-4","article-title":"A chemical biology toolbox to study protein methyltransferases and epigenetic signaling","volume":"10","author":"Scheer","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2025.10.007_bb0430","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41578-020-00269-6","article-title":"Targeted drug delivery strategies for precision medicines","volume":"6","author":"Manzari","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.it.2025.10.007_bb0435","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41467-020-15884-8","article-title":"Improved GPCR ligands from nanobody tethering","volume":"11","author":"Cheloha","year":"2020","journal-title":"Nat. Commun."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490625002510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490625002510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:11:23Z","timestamp":1772125883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490625002510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1471490625002510"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2025.10.007","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetically programmed identity crisis to combat diffuse large B cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2025.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}